Compare $PASG vs $PHIO | Chartloom

Compare

$PASG vs $PHIO

Passage Bio Inc · Phio Pharmaceuticals Corp

PASG

Passage Bio Inc

PHIO

Phio Pharmaceuticals Corp

Compare $PASG vs $PHIO

Comparing Passage Bio Inc and Phio Pharmaceuticals Corp

PASGPassage Bio Inc

PHIOPhio Pharmaceuticals Corp

PASGPassage Bio Inc

Market cap

$12M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-68.4%

52W performance

-55.4%

FCF yield

-282.8%

PHIOPhio Pharmaceuticals Corp

Market cap

$11M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-10.2%

52W performance

-59.6%

FCF yield

-107.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

PASG

PHIO

Detailed metrics comparison

PASG

Passage Bio Inc

PHIO

Phio Pharmaceuticals Corp

Market Cap

PASG$12M

PHIO$11M

Enterprise Value

PASG$-12M

PHIO$-2M

Price

PASG$3.69

PHIO$0.98

P/E Ratio

PASGN/A

PHION/A

P/S Ratio

PASG0.00x

PHIO81.74x

EV/Sales

PASG0.00x

PHIO-11.08x

EV/EBITDA

PASG0.00x

PHIO0.00x

P/B Ratio

PASG2.98x

PHIO0.91x

P/FCF Ratio

PASGN/A

PHION/A

EV/FCF

PASG0.37x

PHIO0.13x

PEG Ratio

PASGN/A

PHION/A

Forward P/E (NTM)

PASGN/A

PHION/A

Forward P/S (NTM)

PASGN/A

PHION/A

Revenue (TTM)

PASG$0

PHIO$0

Revenue Growth (YoY)

PASGN/A

PHION/A

Forward Rev Growth

PASG582.0%

PHIO0.0%

Gross Margin (TTM)

PASG0.0%

PHIO0.0%

Operating Margin (TTM)

PASG0.0%

PHIO0.0%

EBITDA Margin (TTM)

PASG0.0%

PHIO0.0%

Net Margin (TTM)

PASG0.0%

PHIO0.0%

FCF Margin (TTM)

PASGN/A

PHION/A

Net Income (TTM)

PASG$-36M

PHIO$-13M

FCF (TTM)

PASG$-34M

PHIO$-12M

EPS (TTM)

PASG-$11.25

PHIO-$1.11

ROE (TTM)

PASG-21859.0%

PHIO-8741.0%

ROA (TTM)

PASG-7292.0%

PHIO-7976.0%

ROIC (TTM)

PASG-21859.0%

PHIO-8741.0%

Cash

PASG$24M

PHIO$13M

Debt

PASG$0

PHIO$0

Net Cash/Debt

PASG$24M

PHIO$13M

Current Ratio (TTM)

PASG1.22x

PHIO8.39x

Quick Ratio (TTM)

PASG1.17x

PHIO7.62x

Debt/Equity (TTM)

PASG0.00x

PHIO0.00x

Debt/Assets (TTM)

PASG0.0%

PHIO0.0%

Interest Coverage (TTM)

PASGN/A

PHION/A

Net Debt/EBITDA (TTM)

PASG0.00x

PHIO0.00x

Beta

PASG1.48

PHIO0.90

52W Performance

PASG-55.4%

PHIO-59.6%

YTD Performance

PASG-68.4%

PHIO-10.2%

% from 52W High

PASG-81.5%

PHIO-76.6%

% from 52W Low

PASG12.2%

PHIO20.8%

Asset Turnover (TTM)

PASG0.00x

PHIO0.02x

FCF Yield (TTM)

PASG-282.8%

PHIO-107.3%

Earnings Yield (TTM)

PASG-304.9%

PHIO-113.5%

Dividend Yield (TTM)

PASGN/A

PHION/A

Rule of 40

PASG0.0

PHIO0.0

EV/GP/RG

PASGN/A

PHION/A

Ticker research

View PASG research View PHIO research

Metric	PASG Passage Bio Inc	PHIO Phio Pharmaceuticals Corp
Market & Valuation
Market Cap	$12M	$11M
Enterprise Value	$-12M	$-2M
Price	$3.69	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	81.74x
EV/Sales	0.00x	-11.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.98x	0.91x
P/FCF Ratio	N/A	N/A
EV/FCF	0.37x	0.13x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	582.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-36M	$-13M
FCF (TTM)	$-34M	$-12M
EPS (TTM)	-$11.25	-$1.11
ROE (TTM)	-21859.0%	-8741.0%
ROA (TTM)	-7292.0%	-7976.0%
ROIC (TTM)	-21859.0%	-8741.0%
Financial Health
Cash	$24M	$13M
Debt	$0	$0
Net Cash/Debt	$24M	$13M
Current Ratio (TTM)	1.22x	8.39x
Quick Ratio (TTM)	1.17x	7.62x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.48	0.90
52W Performance	-55.4%	-59.6%
YTD Performance	-68.4%	-10.2%
% from 52W High	-81.5%	-76.6%
% from 52W Low	12.2%	20.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-282.8%	-107.3%
Earnings Yield (TTM)	-304.9%	-113.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View PASG research	View PHIO research

Valuation

P/S Ratio

PASG

0.00x

PHIO

81.74x

EV/FCF

PHIO

0.13x

PASG

0.37x

Growth & revenue

Forward Revenue Growth

PASG

582.0%

PHIO

0.0%

Profitability & performance

Gross Margin

PASG

0.0%

PHIO

0.0%

ROE

PHIO

-8741.0%

PASG

-21859.0%

FCF Yield %

PHIO

-107.3%

PASG

-282.8%

52-Week Performance

PASG

-55.4%

PHIO

-59.6%

Detailed metrics comparison

PASG

Passage Bio Inc

PHIO

Phio Pharmaceuticals Corp

Market Cap

PASG$12M

PHIO$11M

Enterprise Value

PASG$-12M

PHIO$-2M

Price

PASG$3.69

PHIO$0.98

P/E Ratio

PASGN/A

PHION/A

P/S Ratio

PASG0.00x

PHIO81.74x

EV/Sales

PASG0.00x

PHIO-11.08x

EV/EBITDA

PASG0.00x

PHIO0.00x

P/B Ratio

PASG2.98x

PHIO0.91x

P/FCF Ratio

PASGN/A

PHION/A

EV/FCF

PASG0.37x

PHIO0.13x

PEG Ratio

PASGN/A

PHION/A

Forward P/E (NTM)

PASGN/A

PHION/A

Forward P/S (NTM)

PASGN/A

PHION/A

Revenue (TTM)

PASG$0

PHIO$0

Revenue Growth (YoY)

PASGN/A

PHION/A

Forward Rev Growth

PASG582.0%

PHIO0.0%

Gross Margin (TTM)

PASG0.0%

PHIO0.0%

Operating Margin (TTM)

PASG0.0%

PHIO0.0%

EBITDA Margin (TTM)

PASG0.0%

PHIO0.0%

Net Margin (TTM)

PASG0.0%

PHIO0.0%

FCF Margin (TTM)

PASGN/A

PHION/A

Net Income (TTM)

PASG$-36M

PHIO$-13M

FCF (TTM)

PASG$-34M

PHIO$-12M

EPS (TTM)

PASG-$11.25

PHIO-$1.11

ROE (TTM)

PASG-21859.0%

PHIO-8741.0%

ROA (TTM)

PASG-7292.0%

PHIO-7976.0%

ROIC (TTM)

PASG-21859.0%

PHIO-8741.0%

Cash

PASG$24M

PHIO$13M

Debt

PASG$0

PHIO$0

Net Cash/Debt

PASG$24M

PHIO$13M

Current Ratio (TTM)

PASG1.22x

PHIO8.39x

Quick Ratio (TTM)

PASG1.17x

PHIO7.62x

Debt/Equity (TTM)

PASG0.00x

PHIO0.00x

Debt/Assets (TTM)

PASG0.0%

PHIO0.0%

Interest Coverage (TTM)

PASGN/A

PHION/A

Net Debt/EBITDA (TTM)

PASG0.00x

PHIO0.00x

Beta

PASG1.48

PHIO0.90

52W Performance

PASG-55.4%

PHIO-59.6%

YTD Performance

PASG-68.4%

PHIO-10.2%

% from 52W High

PASG-81.5%

PHIO-76.6%

% from 52W Low

PASG12.2%

PHIO20.8%

Asset Turnover (TTM)

PASG0.00x

PHIO0.02x

FCF Yield (TTM)

PASG-282.8%

PHIO-107.3%

Earnings Yield (TTM)

PASG-304.9%

PHIO-113.5%

Dividend Yield (TTM)

PASGN/A

PHION/A

Rule of 40

PASG0.0

PHIO0.0

EV/GP/RG

PASGN/A

PHION/A

Ticker research

View PASG research View PHIO research

Metric	PASG Passage Bio Inc	PHIO Phio Pharmaceuticals Corp
Market & Valuation
Market Cap	$12M	$11M
Enterprise Value	$-12M	$-2M
Price	$3.69	$0.98
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	81.74x
EV/Sales	0.00x	-11.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.98x	0.91x
P/FCF Ratio	N/A	N/A
EV/FCF	0.37x	0.13x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	582.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-36M	$-13M
FCF (TTM)	$-34M	$-12M
EPS (TTM)	-$11.25	-$1.11
ROE (TTM)	-21859.0%	-8741.0%
ROA (TTM)	-7292.0%	-7976.0%
ROIC (TTM)	-21859.0%	-8741.0%
Financial Health
Cash	$24M	$13M
Debt	$0	$0
Net Cash/Debt	$24M	$13M
Current Ratio (TTM)	1.22x	8.39x
Quick Ratio (TTM)	1.17x	7.62x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.48	0.90
52W Performance	-55.4%	-59.6%
YTD Performance	-68.4%	-10.2%
% from 52W High	-81.5%	-76.6%
% from 52W Low	12.2%	20.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.02x
FCF Yield (TTM)	-282.8%	-107.3%
Earnings Yield (TTM)	-304.9%	-113.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View PASG research	View PHIO research